TICKERNOMICS Sign up
Last Update: 2023-12-23 06:01:35
NeuroPace Inc ( NPCE ) https://www.neuropace.com
8.84USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
NPCE
550.00%
SPY
30.72%
NPCE
0.00%
SPY
112.82%
NPCE
0.00%
SPY
201.04%
NPCE
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
257.57
279.21
0.05
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-5.96
4.28
15.74
-11.78
0.00
-9.24
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-36.22
74.47
-50.21
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
3.86
-73.83
-24.69
0.00
Other Earnings and Cash Flow Stats:
NeuroPace Inc ( NPCE ) Net Income TTM ($MM) is -47.46
NeuroPace Inc ( NPCE ) Operating Income TTM ($MM) is -34.33
NeuroPace Inc ( NPCE ) Owners' Earnings Annual ($MM) is 0.00
NeuroPace Inc ( NPCE ) Current Price to Owners' Earnings ratio is 0.00
NeuroPace Inc ( NPCE ) EBITDA TTM ($MM) is -31.91
NeuroPace Inc ( NPCE ) EBITDA Margin is -50.21%
Capital Allocation:
NeuroPace Inc ( NPCE ) has paid 0.00 dividends per share and bought back -1.288628 million shares in the past 12 months
NeuroPace Inc ( NPCE ) has increased its debt by 4.234 million USD in the last 12 months
Capital Structure:
NeuroPace Inc ( NPCE ) Interest-bearing Debt ($MM) as of last quarter is 73
NeuroPace Inc ( NPCE ) Annual Working Capital Investments ($MM) are -16
NeuroPace Inc ( NPCE ) Book Value ($MM) as of last quarter is 16
NeuroPace Inc ( NPCE ) Debt/Capital as of last quarter is 447%
Other Balance Sheet Stats:
NeuroPace Inc ( NPCE ) has 9 million in cash on hand as of last quarter
NeuroPace Inc ( NPCE ) has 12 million of liabilities due within 12 months, and long term debt 55 as of last quarter
NeuroPace Inc ( NPCE ) has 26 common shares outstanding as of last quarter
NeuroPace Inc ( NPCE ) has 0 million USD of preferred stock value
Academic Scores:
NeuroPace Inc ( NPCE ) Altman Z-Score is -4.75 as of last quarter
NeuroPace Inc ( NPCE ) Piotroski Score is 4.00 as of last quarter
Corporate Governance:
NeuroPace Inc ( NPCE ) largest shareholder is Bridgeway Capital Management, LLC owning 60048 shares at 0.53 ($MM) value
Martha Morrell(an insider) Sold 11005 shares of NeuroPace Inc ( NPCE ) for the amount of $89800.80 on 2023-12-06
8.55% of NeuroPace Inc ( NPCE ) is held by insiders, and 87.08% is held by institutions
NeuroPace Inc ( NPCE ) went public on 2021-04-22
Other NeuroPace Inc ( NPCE ) financial metrics:
FCF:-27.09
Unlevered Free Cash Flow:-54.17
EPS:-1.12
Operating Margin:-36.22
Gross Profit Margin:74.47
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-177.40
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About NeuroPace Inc ( NPCE ) :
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.